Aquestive Therapeutics Inc (AQST)
EBITDA
-$61.39M
TTM · Period ending: · USD
AQST EBITDA
Latest reported-$61.39Mperiod ending
Latest reported-$61.39Mperiod ending
AQST EBITDA ($2.95M → -$61.39M)
Annual EBITDA
High-resolution chart · PNG
AQST ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -66,136,000 | |
| -26,616,000 | |
| 1,182,000 | |
| -39,580,000 | |
| -45,114,000 | |
| -39,318,000 | |
| -54,023,000 | |
| -50,429,000 | |
| 2,565,000 | |
| 2,945,000 |